Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease (NCT07661056)
A Phase 3, Double-blind, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BHV-1300 in the Treatment of Adults With Graves' Disease
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid
Who can join: Review the eligibility criteria below.
Location: Site-032 — Burbank, California
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (30 Sites)
Showing the first 25 of 30 sites.
- Site-032 — Burbank, California
- Site-062 — Huntington Beach, California
- Site-006 — San Diego, California
- Site-067 — Walnut Creek, California
- Site-052 — Doral, Florida
- Site-019 — Hialeah, Florida
- Site-031 — Champaign, Illinois
- Site-025 — Lenexa, Kansas
- Site-046 — Farmington Hills, Michigan
- Site-072 — Las Vegas, Nevada
- Site-038 — Asheville, North Carolina
- Site-011 — Greenville, North Carolina
- Site-063 — Morehead City, North Carolina
- Site-064 — Morehead City, North Carolina
- Site-039 — Raleigh, North Carolina
- Site-033 — Statesville, North Carolina
- Site-045 — Wilmington, North Carolina
- Site-008 — Canton, Ohio
- Site-016 — Chattanooga, Tennessee
- Site-055 — Dallas, Texas
- Site-020 — Dallas, Texas
- Site-043 — Denton, Texas
- Site-042 — El Paso, Texas
- Site-071 — Houston, Texas
- Site-054 — McKinney, Texas
📞 Contact the Study Coordinator
Phone: (203) 404-0410
Email: clinicaltrials@biohavenpharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Graves Disease
- Evaluating an AI Tool for Detecting Thyrotoxic States — San Francisco, California
- Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease — New Hyde Park, New York
- Preoperative Corticosteroids in Autoimmune Thyroid Disease — Indianapolis, Indiana
- Study of BHV-1300 in Graves' Disease — South Gate, California
- NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease — Torrance, California
Explore by condition: All Graves Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.